DEGS1 and metabolic disease: Interestingly, both whole body and tissue specific (liver and/or adipose tissue) DES1 deficiency improves insulin resistance in mice, suggesting DES1 as a novel target against imbalanced glucose handling and metabolic disorders.[69]